Renal allograft protection with losartan in Fisher→Lewis rats: Hemodynamics, macrophages, and cytokines

Kidney International

Volumn 57, Issue 6, 2000, Pages 2618-2625

  Ziai, Farzad ^c   Nagano, Hiroaki ^c   Kusaka, Mamoru ^c   Coito, Ana J ^a,c   Troy, Julia L ^c   Nadeau, Kari C ^b,c   Rennke, Helmut G ^c   Tilney, Nicholas L ^c   Brenner, Barry M ^c   Mackenzie, Harald S ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Pediat Surg Research Laboratories   (United States)

^d Renal Division   (United States)

Author keywords

Angiotensin II; Chronic rejection; Kidney injury; Transplantation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CHEMOATTRACTANT; CYTOKINE; LOSARTAN; RANTES; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GLOMERULUS; GRAFT REJECTION; HEMODYNAMIC MONITORING; KIDNEY ALLOGRAFT; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034117224     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00122.x     Document Type: Article

References (40)

1. 1. FEEHALLY J, HARRIS KP, BENNETI SE, WALLS J: Is chronic renal transplant rejection a non-immunological phenomenon? Lancet 2:486-488, 1986
2. 2. BRENNER BM, COHEN RA, MILFORD EL: In renal transplantation, one size may not fit all. J Am Soc Nephrol 3:162-169, 1992
3. 3. HOSTETTER TH: Chronic transplant rejection. Kidney Int 46:266-279, 1994
4. 4. MACKENZIE HS, TULLIUS SG, HEEMANN UW, AZUMA H, RENNKE HG, BRENNER BM, TILNEY NL: Nephron supply is a major determinant of long-term renal allograft outcome in rats. J Clin Invest 94:2148-2152, 1994
5. 5. TULLIUS SG, HANCOCK WW, HEEMANN U, AZUMA H, TILNEY NL: Reversibility of chronic renal allograft rejection: Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury. Transplantation 58:93-99, 1994
6. 6. TERASAKI PI, CECKA JM, GJERTSON DW, TAKEMOTO S: High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 333:333-336, 1995
7. 7. KINGMA I, CHEA R, DAVIDOFF A, BENEDIKTSSON H, PAUL LC: Glomerular capillary pressures in long-surviving rat renal allografts. Transplantation 56:53-60, 1993
8. 8. JUNAID A, KREN SM, ROSENBERG ME, NATH KA, HOSTETLER TH: Physiological and structural responses to chronic experimental renal allograft injury. Am J Physiol 267:F1102-F1106, 1994
9. 9. MACKENZIE HS, AZUMA H, TROY JL, RENNKE HG, TILNEY NL, BRENNER BM: Augmenting kidney mass at transplantation abrogates chronic renal allograft injury in rats. Proc Assoc Am Physicians 108:128-133, 1996
10. 10. ANDERSON S, MEYER TW, RENNKE HG, BRENNER BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612-619, 1985
11. 11. LAFAYETTE RA, MAYER G, PARK SK, MEYER TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90:766-771, 1992
12. 12. MACKENZIE HS, OTS M, ZIAI F, LEE KW, KATO S, BRENNER BM: Angiotensin receptor antagonists in experimental models of chronic renal failure. Kidney Int 52(Suppl 63):S140-S143, 1997
13. 13. BENEDIKTSSON H, CHEA R, DAVIDOFF A, PAUL LC: Antihypertensive drug treatment in chronic renal allograft rejection in the rat: Effect on structure and function. Transplantation 62:1634-1642, 1996
14. 14. MACKENZIE HS, ZIAI F, NAGANO H, AZUMA H, TROY JL, RENNKE HG, TILNEY NL, BRENNER BM: Candesartan cilexetil reduces chronic renal allograft injury in Fisher - Lewis rats. J Hypertens 15(Suppl 6):21-25, 1997
15. 15. AMUCHASTEGUI SC, AZZOLLINI N, MISTER M, PEZZOTTA A, PERICO N, RLMUZZI G: Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism. J Am Soc Nephrol 9:1948-1955, 1998
16. 16. KAGAMI S, BORDER WA, MILLER DE, NOBLE NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
17. 17. HERNANDEZ PM, BUSTOS C, ORIEGO M, TUNON J, RENEDO G, RUTZ OM, EGIDO J: Angiotensin-converting Enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95:1532-1541, 1997
18. 18. RUIZ-ORTEGA M, BUSTOS C, HERNANDEZ PM, LORENZO O, PLAZA JJ, EGIDO J: Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol 161:430-439, 1998
19. 19. WEBER KT, SUN Y, GUARDA E: Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension 23(6 Pt 2):869-877, 1994
20. 20. DIAMOND JR, TILNEY NL, FRYE J, DING G, MCELROY J, PESFKDIAMOND I, YANG H: Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection. Transplantation 54:710-716, 1992
21. 21. HANCOCK WH, WHITLEY WD, TULLIUS SG, HEFMANN UW, WASOWSKA B, BALDWIN WD, TILNEY NL, BALDWIN WM: Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 56:643-650, 1993
22. 22. NADEAU KC, AZUMA H, TILNEY NL: Sequential cytokine dynamics in chronic rejection of rat renal allografts: Roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci USA 92:8729-8733, 1995
23. 23. RENNKE HG, KLEIN PS: Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 443-456, 1989
24. 24. FÜHR J, KAMARCZYK J, KRÜTTGEN CD: Eine einfache colorimetrische methode zur inulinbestimmung für nieren-clearance-untersuchungen bei stoffwechselgesunden und diabetikern. Klin Wochenschr 33:729-730, 1955
25. 25. VUREK GG, PEGRAM SE: Fluorometric method for the determination of nanogram quantities of inulin. Anal Biochem 16:409-419, 1966
26. 26. PLATZER C, ODE HS, REINKE P, DOCKE WD, EWERT R, VOLK HD: Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. Transplantation 58:264-268, 1994
27. 27. CHEHADEH HE, ZERLAUTH G, MANNHALTER JW: Video image analysis of quantitative competitive PCR products: Comparison of different evaluation methods. Biotechniques 18:26-28, 1995
28. 28. CARPENTER CB: Long-term failure of renal transplants: Adding insult to injury. Kidney Int 48(Suppl 50):40-44, 1995
29. 29. SCHRECK R, MEILR B, MANNEL D, DROGE W, BAEUERLE P: Dithiocarhamates as potent inhibitor of nuclear factor kappa B activation in intact cells. J Exp Med 175:1181-1194, 1992
30. 30. GRIENDLING KK, USHIO FM, LASSEGUE B, ALEXANDER RW: Angiotensin II signaling in vascular smooth muscle: New concepts. Hypertension 29(1 Pt 2):366-373, 1997
31. 31. THOMAS DW, HOFFMAM MD: Identification of macrophage receptors for angiotensin: A potential role in antigen uptake for T lymphocyte responses? J Immunol 132:2807-2812, 1984
32. 32. WEINSTOCK JV, KASSAB J: Chemotactic response of splenic mono-nuclear cells to angiotensin II in murine schistosomiasis. J Immunol 137:2020-2024, 1986
33. 33. AZUMA H, NADEAU KC, ISHIBASHI M, TILNEY NL: Prevention of functional, structural, and molecular changes of chronic rejection of rat renal allografts by a specific macrophage inhibitor. Transplantation 60:1577-1582, 1995
34. 34. NAGANO H, NADEAU KC, KUSAKA M, HEEMAN UW, TILNEY NL: Infection-associated macrophage activation accelerates chronic renal allograft rejection in rats. Transplantation 64:1602-1605, 1997
35. 35. RISER BL, CORTES P, ZHAO X, BERNSTEIN J, DUMLER F, NARINS RG: Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 90:1932-1943, 1992
36. 36. CAPERS Q 4th, ALEXANDER RW, LOU P, DE LEON H, WILCOX JN, ISHIZAKA N, HOWARD AB, TAYLOR WR: Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 30:1397-1402, 1997
37. 37. BENIGNI A, ZOJA C, REMUZZI G: Biology of disease: The renal toxicity of sustained glomerular protein traffic. Lab Invest 73:461-468, 1995
38. 38. REMUZZI G, RUGGENENTI P, BENIGNI A: Understanding the nature of renal disease progression. Kidney Int 51:2-15, 1997
39. 39. WOLF G, ZIYADEH FN: Renal tubular hypertrophy induced by angiotensin II. Semin Nephrol 17:448-454, 1997
40. 40. WOLF G, KALLURI, ZIYADH FN, NEILSON EG, SLAHI, RA: Angiotensin II induces alpha3 (IV) collagen expression in cultured murine proximal tubular cells. Proc Assoc Am Physicians 111:357-364, 1999